(Q42476473)

1 November 2017

title

Intralesional alpha 2b recombinant interferon for basal cell carcinomas (English)

1 reference

1 November 2017

Boneschi V

1

1 reference

1 November 2017

Brambilla L

2

1 reference

1 November 2017

Chiappino G

3

1 reference

1 November 2017

Mozzanica N

4

1 reference

1 November 2017

Finzi AF

5

1 reference

1 November 2017

publication date

1 March 1991

1 reference

International Journal of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

30

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

220-224

1 reference

Virus interference. I. The interferon

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1991.TB03859.X

Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1991.TB03859.X

Immune interferon: a pleiotropic lymphokine with multiple effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1991.TB03859.X

Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1991.TB03859.X

10.1111/J.1365-4362.1991.TB03859.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference